Provenge Immunotherapy for Prostate Cancer - Allan J. Pantuck, MD - UCLAMDChat

Provenge Immunotherapy for Prostate Cancer - Allan J. Pantuck, MD - UCLAMDChat

UCLA Health via YouTube Direct link

FDA Approved Immunotherapies

14 of 25

14 of 25

FDA Approved Immunotherapies

Class Central Classrooms beta

YouTube videos curated by Class Central.

Classroom Contents

Provenge Immunotherapy for Prostate Cancer - Allan J. Pantuck, MD - UCLAMDChat

Automatically move to the next video in the Classroom when playback concludes

  1. 1 Introduction
  2. 2 Cancer
  3. 3 Prostate Cancer
  4. 4 Treatment
  5. 5 What is Provenge
  6. 6 What is autologous
  7. 7 Features of cancer
  8. 8 Immune surveillance
  9. 9 What is immunotherapy
  10. 10 Origins of immunotherapy
  11. 11 Advantages of immunotherapy
  12. 12 Breakthrough of the year
  13. 13 Immunotherapy
  14. 14 FDA Approved Immunotherapies
  15. 15 What is a Therapeutic Vaccine
  16. 16 Treatment Window
  17. 17 Why Provenge
  18. 18 Side Effects
  19. 19 Day of the Infusion
  20. 20 Self Limited Course
  21. 21 Summary
  22. 22 Who is most likely to benefit
  23. 23 What is PSA
  24. 24 Effectiveness
  25. 25 Other immunotherapies

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.